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Abstract
Background: αA-crystallin is highly expressed in the embryonic, neonatal and adult mouse lens.
Previously, we identified two novel distal control regions, DCR1 and DCR3. DCR1 was required
for transgenic expression of enhanced green fluorescent protein, EGFP, in lens epithelium, whereas
DCR3 was active during "late" stages of lens primary fiber cell differentiation. However, the onset
of transgenic EGFP expression was delayed by 12–24 hours, compared to the expression of the
endogenous Cryaa gene.
Results: Here, we used bacterial artificial chromosome (BAC) and standard transgenic approaches
to examine temporal and spatial regulation of the mouse Cryaa gene. Two BAC transgenes, with
EGFP insertions into the third coding exon of Cryaa gene, were created: the intact αA-crystallin 148
kb BAC (αA-BAC) and αA-BAC(ΔDCR3), which lacks approximately 1.0 kb of genomic DNA
including DCR3. Expression of EGFP in the majority of both BAC transgenics nearly recapitulated
the endogenous expression pattern of the Cryaa gene in lens, but not outside of the lens. The
number of cells expressing αA-crystallin in the lens pit was higher compared to the number of cells
expressing EGFP. Next, we generated additional lines using a 15 kb fragment of αA-crystallin locus
derived from αA-BAC(ΔDCR3), 15 kb Cryaa/EGFP. A 15 kb region of Cryaa/EGFP supported the
expression pattern of EGFP also in the lens pit. However, co-localization studies of αA-crystallin
and EGFP indicated that the number of cells that showed transgenic expression was higher
compared to cells expressing αA-crystallin in the lens pit.
Conclusion: We conclude that a 148 kb αA-BAC likely contains all of the regulatory regions
required for αA-crystallin expression in the lens, but not in retina, spleen and thymus. In addition,
while the 15 kb Cryaa/EGFP region also supported the expression of EGFP in the lens pit, expression
in regions such as the hindbrain, indicate that additional genomic regions may play modulatory
functions in regulating extralenticular αA-crystallin expression. Finally, deletion of DCR3 in either
αA-BAC(ΔDCR3) or Cryaa (15 kb) transgenic mice result in EGFP expression patterns that are
consistent with DCR's previously established role as a distal enhancer active in "late" primary lens
fiber cells.
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Background
Gene regulation during embryonic development is regu-
lated at the DNA level by a number of proximal (promot-
ers) and distal (enhancers, silencers, insulators and locus
control regions) regulatory regions that are organized by a
variety of histone and non-histone proteins present in
chromatin [1]. Ocular lens development has been exten-
sively studied to address the molecular mechanisms that
control tissue-specific, temporal and spatial gene regula-
tion [2,3]. The mammalian lens is composed of two cell
types, the anterior proliferating lens epithelial cells and
the posterior differentiating lens fiber cells, both of a sin-
gle progenitor origin. Lens fiber cells are characterized by
a high concentration of crystallins, a family of proteins
which constitute 90% of the water soluble proteins, and
act as structural proteins in the lens [4-6]. These crystallins
play key roles in maintaining lens transparency and in
generating its refractive index. The relative simplicity of
the lens embryonic origin, and its structure, make it an
ideal model system to study the complexities of gene reg-
ulation [2,3].
Lens fiber cell differentiation is accompanied by the accu-
mulation of high levels of αA-crystallin, representing 20–
40% of the crystallin content of the human and mouse
lens [4-6]. In addition to its role as a structural protein,
αA-crystallin is also a member of the small heat shock
protein family, thereby functioning as a molecular chap-
erone that prevents protein aggregation [7], and possesses
an autokinase activity [8]. Disruption of αA-crystallin
results in the formation of cataracts [9,10] (see MGI web-
site for Cryaa  phenotypic alleles), and has also been
shown to result in apoptosis of lens epithelial cells [11],
illustrating its vital role for lens homeostasis [9,10] (see
MGI website for Cryaa phenotypic alleles). Furthermore,
genetic studies in humans have shown that numerous αA-
crystallin missense mutations result in cataract formation
[10,12-19]. More recent studies have shown that αA-crys-
tallin binds to and suppresses caspase 6 activity [20].
Although αA-crystallin is expressed predominantly in the
lens, low levels of its expression have been reported in the
retina, spleen and thymus [21,22]. However, no specific
function of αA-crystallin has been shown in these tissues.
Our recent studies have identified two αA-crystallin lens-
specific enhancers, DCR1 (located ~-8 kb) and DCR3
(located ~+3 kb, following the last Cryaa exon) [23] as
novel distal regulatory regions involved in transcriptional
regulation of the αA-crystallin gene. Conventional trans-
genic approaches utilizing DCR1 and DCR3 fused to the
1.9 kb αA-crystallin promoter were successful in express-
ing EGFP in both lens epithelium and fiber cells. How-
ever, while endogenous αA-crystallin expression was first
apparent in the lens pit at E10.5, these transgenics
expressed EGFP one day later in the lens vesicle, leading us
to hypothesize that additional cis  regulatory elements
were required to recapitulate endogenous αA-crystallin
expression. In this study we utilized BAC transgenics as a
means to dissect further the transcriptional regulation of
the αA-crystallin gene. Our main goal was to narrow down
the genomic region(s) that harbour lens-specific essential
regulatory regions required for the initiation of αA-crystal-
lin gene expression in the lens pit.
Results
Endogenous αA-crystallin expression in mouse eye
Consistent with previous reports of αA-crystallin mRNA
expression monitored by in situ hybridizations [24],
endogenous  αA-crystallin protein expression is first
apparent in the lens pit at E10.5 (compare Fig. 1A with
Fig. 1B). Expression is up-regulated at E11.5 in the lens
vesicle (Fig. 1C) and continues to be highly expressed in
the differentiating primary fiber cells at E14.5 (Fig. 1D),
and within the fiber cells of the newborn lens (Fig 1E, F).
Lower levels of αA-crystallin are expressed in lens epithe-
lium compared to lens fiber cells of the postnatal day 1
(PND1) lens (Fig. 1F).
Expression pattern of EGFP driven by 148 kb Cryaa BAC, 
αA-BAC
Prior studies identified two distal control regions, DCR1
and DCR3 (Fig. 2A), that, in combination with a 1.9 kb
promoter fragment, recapitulate most aspects of transcrip-
tional regulation of αA-crystallin [23]. However, in these
studies, the onset of EGFP expression was between E11-
E11.5, which is at least 12 hours after the onset of endog-
enous αA-crystallin expression (see Fig. 1B). This finding
suggests other regulatory regions could be required. To
address this, we generated a BAC transgenic by modifying
a 148 kb BAC encompassing the αA-crystallin gene (see
Fig. 2A) through an in frame insertion of EGFP into the
third exon, by homologous recombination according to
[25] (see Fig. 2B). EGFP was inserted after V146, close to
the C-end of the 173 amino acid αA-crystallin. Four
founders were generated, but only three were studied due
to breeding difficulties encountered with the fourth
founder. All founders had visually green eyes, and trans-
gene integrations were subsequently confirmed by geno-
typing. The copy number of the transgenic lines was
determined by qPCR (Table 1) as described in Methods.
Embryonic EGFP expression analysis revealed that all
three lines first express EGFP at E10.5 (Fig. 3A, F), which
is temporally congruent with the onset of endogenous αA-
crystallin expression (Fig. 1). Though EGFP is expressed in
the lens vesicle at E11.5 (Fig. 3B, G), it becomes signifi-
cantly upregulated at E12.5 in the differentiating primary
lens fiber cells. Significantly lower EGFP expression was
found in a small number of the overlying epithelial cells
compared to the primary lens fiber cell compartment (Fig.BMC Developmental Biology 2008, 8:88 http://www.biomedcentral.com/1471-213X/8/88
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3C, H). This pattern of EGFP expression continues
through E14.5 (Fig. 3D, I; see Additional file 1A for
expression in lens epithelial cells) and in the PND1 lens
(Fig. 3E, J; Additional file 1B), with high levels present in
the differentiating lens fiber cells and lower expression
evident in some cells of the lens epithelium. Thus, expres-
sion of EGFP inserted into the 148 kb Cryaa BAC (Fig. 2),
due to its earlier onset, better recapitulates the expression
patterns of endogenous αA-crystallin in lens (Fig. 1) when
compared to the expression from DCR1/αA/EGFP trans-
genes [23].
Removal of a 1.0 kb region containing DCR3 does not 
affect early αA-crystallin/EGFP expression in αA-
BAC(ΔDCR3)
To test if DCR3 is essential for expression of Cryaa gene,
we generated a BAC transgene which lacks approximately
1.0 kb of the Cryaa  genomic region, including DCR3
downstream of the third exon (nucleotides +3,171 to
+4,197) (see Fig. 2C). This results from a genomic dele-
tion that occurs simultaneously with the insertion of
EGPF into the third exon using the pLD53.SC-AB shuttle
vector [26]. Three lines are generated which express EGFP
and contain two to five copies of the transgene (see Table
1).
Similar to αA-BAC, EGFP expression is first evident in the
lens pit at E10.5 (Fig. 4A, F) in one of the three αA-BAC
(ΔDCR3) lines. Expression of EGFP is also detected in the
lens vesicle (Fig. 4B, G) and is upregulated considerably in
the differentiating lens fiber cells at E12.5 (Fig. 4C, H). As
development progresses, EGFP is intensely expressed in
the lens fiber cells at E14.5 (Fig. 4D, I; Additional file 1C)
and PND 1 (Fig. 4E, J; Additional file 1D). Lower EGFP is
also evident in some lens epithelial cells at these stages
(Additional file 1C, D). The remaining two lines (see
Table 1 and 2) have a delayed onset of EGFP expression,
αA-crystallin protein expression during lens morphogenesis Figure 1
αA-crystallin protein expression during lens morphogenesis. Nuclear DAPI staining is blue and αA-crystallin immu-
nolabeling is red. αA-crystallin is not expressed at E9.5 in the lens placode (A) but becomes visible in the lens pit at E10.5 (B). 
Expression intensifies in the developing lens vesicle at E11.5 (C), and is evident in the newly differentiated fiber cells at E14.5 
(D), as well as within the lens epithelium. αA-crystallin expression continues in the fiber (E) and epithelial cells of the P1 lens 
(F). Lens epithelial cells, e; lens fiber cells, f; lens vesicle, lv; lens pit, lp. Scale bar = 100 μm.
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Schematic representation of three αA-crystallin transgene constructs Figure 2
Schematic representation of three αA-crystallin transgene constructs. (A) A schematic diagram of the mouse Cryaa 
locus (chromosome 17) and its adjacent loci, U2af1 and Snf1lk. The 148 kb BAC Clone RP-23-465G4 is shown in red. The 
XmaI-SpeI sites delineate 15 kb of the Cryaa locus. Exons in the Cryaa gene (black box), DCR1 and DCR3 (orange box), centro-
mere, cen; telomere, tel; Exon, ex; rodent specific Cryaa exon, Ins. (B) Modification of αA-BAC using the λ prophage system 
for homologous recombination [25]. (C) Generation of αA-BAC(ΔDCR3) using a shuttle vector [26]. (D) Diagrammatic repre-
sentation of the 15 kb portion of the mouse αA-crystallin locus with an EGFP insert (see panel (C)) marked by unique XmaI 
and SpeI restriction sites.
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first found in the lens vesicle stage of development (data
not shown).
A 15 kb αA-crystallin/EGFP fragment which lacks DCR3 
is sufficient for the earliest expression in the lens pit
The distance between the 5' end of DCR1 to the 3' border
of DCR3 in mouse is approximately 13 kb and is marked
by a corresponding domain of lens-specific chromatin
[23]. In addition, our present (see Fig. 4) and earlier data
[23] suggest that DCR3 may not be required for expres-
sion either in the lens pit or lens vesicle. To narrow down
the genomic region required for EGFP expression in the
lens pit, we released a 15 kb XmaI-SpeI Cryaa/EGFP frag-
ment from αA-BAC (ΔDCR3) (see Fig. 2D) and used it to
generate six transgenic founders, all of which expressed
EGFP in the lens. The two lines showing the lowest expres-
sion of EGFP were not analyzed further.
All four remaining lines expressed EGFP at E10.5 in the
invaginating lens pit (Fig. 5A, F). As development pro-
gressed, strong EGFP was found throughout the lens vesi-
cle at E11.5 (Fig. 5B, G). In addition to the characteristic
upregulation of EGFP in the differentiating fiber cells at
E12.5, all transgenic lines also displayed intense EGFP
expression in the lens epithelium (Fig. 5C, H), which was
less evident in the αA-crystallin BAC transgenics (compare
with Fig. 3C, H and Fig. 4C, H). Similarly, the lens epithe-
lial cells at E14.5 (Fig. 5D, I; Additional file 1E) and at
postnatal day 1 (Fig. 5E, J; Additional file 1F) also dis-
played stronger EGFP expression in the lens epithelium
compared to their BAC counterparts. However, while high
levels of EGFP expression were observed in lens, numer-
ous embryos from different lines also exhibited extralen-
ticular expression in regions such as the hindbrain, and
other areas of the head (Fig. 6). From these results we con-
clude that expression of αA-crystallin/EGFP in the lens pit
is regulated by one or more enhancers present presumably
Table 1: Summary of transgenic mice used to study Cryaa expression in lens.
Constructs Regulatory 
Elements
Copy Number 
Range
Onset of 
Expression
Expression 
Location
αA-BAC 4 lines* 148 kb BAC 2–3 E10.5 (3/3) Lens (epithelium and fiber cells)
αA-BAC(ΔDCR3) 3 lines 148 kb BAC-DCR3 
(with 1 kb deletion)
2–5 E10.5 (1/3) Lens (epithelium and fiber cells)
Cryaa (15 kb) 6 lines/analyzed 4 15 kb Cryaa (-DCR3) 5–15 E10.5 (4/4) Lens (epithelium and fiber cells) Brain
* One line had breeding issues and was not studied
Expression analysis of αA-BAC transgenic mice Figure 3
Expression analysis of αA-BAC transgenic mice. EGFP expression at E10.5 in the lens pit (A, F) and within the E11.5 lens 
vesicle (B, G). Expression is upregulated in lens fiber cells at E12.5, and very small expression is also apparent in a few cells of 
the lens epithelium (arrow) (C, H). Strong EGFP expression continues in the fiber cells at E14.5 (D, I) and in the PND1 lens (E, 
J). Nuclei are stained blue with DAPI, and the cytoskeletal staining is red. Lens fiber cells, f; lens pit, lp; lens vesicle, lv. Scale bar 
= 100 μm.
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within the 15 kb XmaI-SpeI genomic fragment, function-
ally distinct from DCR3.
Transgene expression of EGFP compared to endogenous 
αA-crystallin expression
Immunolabeling with anti-αA-crystallin antibody was
conducted to evaluate co-expression with the transgenes
visualized via EGFP. The representative data on αA-crys-
tallin (red channel) and EGFP (green channel) proteins
are shown in Fig. 7. A few yellow (merged red and green
signals) cells in the lens pit of αA-BAC (Fig. 7A) and αA-
BAC(ΔDCR3) (Fig. 7F) transgenics at E10.5 demonstrate
co-expression of EGFP and αA-crystallin (red staining).
However, while the expression of αA-crystallin seems to
prevail over EGFP in the lens pit (E10.5) in both BAC
models, it appears that transgene EGFP is catching up to
endogenous  αA-crystallin as more yellow signal is
observed at E12.5 (Fig. 7C, H) compared to E11.5 (Fig.
7B, G). In contrast, co-expression analysis of the 15 kb
Cryaa/EGFP unit at E10.5 (Fig. 7K), shows more cells with
a stronger EGFP signal over the αA-crystallin.
At E11.5, while a small number of cells appeared to co-
express αA-crystallin and EGFP in the lens vesicle of the
αA-BAC transgenics (Fig. 7B, G), far more cells co-
expressed apparently both proteins in αA-BAC(ΔDCR3)
(Fig. 7G, see yellow cells) and in the 15 kb Cryaa/EGFP
lenses (Fig. 7L). Coinciding with the onset of lens fiber
cell differentiation at E12.5, lines from all three trangenes
displayed significant co-expression of both proteins in
lens primary fiber cells (Fig. 7C, H, M). At E14.5 (Fig. 7D,
I, N) and postnatally (Fig. 7E, J, O), most lens fiber cells
gave very strong EGFP signals over the red signals that
originated from both the endogenous and fusion/EGFP
proteins (see Discussion).
αA-BAC(ΔDCR3) transgene expression in the lens Figure 4
αA-BAC(ΔDCR3) transgene expression in the lens. Expression of EGFP from αA-BAC(ΔDCR3) is first observed at 
E10.5 in the lens pit (A, F). EGFP is expressed in the lens vesicle at E11.5 (Fig. B, G) and within the differentiating primary fiber 
cells at E12.5 (C, H), E14.5 (D, I) and in PND 1 lens (E, J). Fluorescent nuclear DAPI staining is blue and cytoskeletal staining is 
red. Lens fiber cells, f; lens pit, lp; lens vesicle, lv. Scale bar = 100 μm.
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Table 2: Relative expression of EGFP compared to αA-crystallin in transgenic lenses.
Constructs Regulatory Elements EGFP/αA RNA **
αA-BAC 148 kb BAC 1.3–47×
αA-BAC(ΔDCR3) 148 kb BAC – DCR3 1.2–6×
Cryaa (15 kb) 15 kb – DCR3 0.44–2.7×
pA425* 1.9 kb promoter + DCR1 0.456
pA427* 1.9 kb promoter + DCR1 + DCR3 0.094
*) Lines shown previously in [23].
**) Range between multiple lines analyzed.BMC Developmental Biology 2008, 8:88 http://www.biomedcentral.com/1471-213X/8/88
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Expression of EGFP in non-lenticular tissues of all 
transgenic models
EGFP expression was not microscopically observed in any
non-lenticular embryonic tissue of αA-BAC or αA-
BAC(ΔDCR3) transgenics. In order to determine whether
EGFP was expressed in any specific non-lenticular tissue,
we performed qRT-PCR analysis of total RNAs obtained
from 1-day old lens, retina, brain, thymus, heart, spleen,
kidney, liver and muscle. We did not detect any expression
of EGFP mRNA by qRT-PCR (Ct > 40, see Methods) in any
non-lenticular tissue examined.
Extralenticular EGFP expression however was visually evi-
dent in the brain and head region of several of the 15 kb
Cryaa/EGFP embryos from multiple lines (Fig. 6). Analy-
ses by qRT-PCR of the Cryaa and EGFP mRNAs (see Meth-
ods) further substantiated exogenous expression in
regions such as the brain, retina, kidney, spleen and mus-
cle and their levels were found to be 0.3%, 0.4%, 0.04%,
0.02% and 0.08% as compared to EGFP expression in the
lens, respectively. These results suggest that regions out-
side of this 15 kb/EGFP fragment, while present in the 148
kb Cryaa BAC, may play a role in modulation of extralen-
ticular expression of αA-crystallin.
Discussion
Initial studies of mouse αA-crystallin gene expression have
shown that the αA-crystallin promoter fragment -366 to
+46 supports expression of a linked CAT gene only in lens
fibers [27,28]. Two novel regulatory regions of the mouse
Cryaa locus, DCR1 and DCR3, have been recently identi-
fied and studied in transgenic mice [23]. Using the DCR1/
1.9 kb promoter/EGFP reporter system, we detect initial
EGFP expression in the lens vesicle (E11.5) although the
onset of endogenous αA-crystallin commences in the
invaginating lens placode/lens pit around E10.5 (Fig. 1).
This finding suggests that other regulatory regions are
required for the proper onset of αA-crystallin expression
as the lens placode invaginates to form the lens pit (Fig.
1). Here, we find that a modified 14 kb region of the
mouse Cryaa locus (a 15 kb transgene containing 14 kb of
genomic Cryaa region with a 1.0 kb insert of EGFP/polyA)
can support robust EGFP expression in the lens pit of
E10.5 mouse embryos (Figs. 5A, F, and 7K), and, thus,
represents a reasonable source from which to identify the
"earliest" enhancer of the Cryaa locus. Moreover, the 148
kb Cryaa BAC is insufficient for appreciable EGFP expres-
sion in the retina, spleen and thymus [22].
Novel insights into the temporal and spatial regulation of 
αA-crystallin gene expression in lens and extralenticular 
tissues
All three αA-BAC transgenic lines display both temporal
and spatial expression patterns of EGFP that are qualita-
tively comparable to those of the endogenous αA-crystal-
lin in lens. EGFP expression is first detected at E10.5 in the
Expression of EGFP from the 15 kb Cryaa/EGFP fragment in lens Figure 5
Expression of EGFP from the 15 kb Cryaa/EGFP fragment in lens. EGFP expression is first evident at E10.5 in the lens 
pit (A, F) and becomes expressed throughout the lens vesicle at E11.5 (B, G). As fiber cell differentiation commences at E12.5 
(C, H), intense EGFP expression is observed. Prominent expression is also evident in the overlaying lens epithelium (C, H). 
EGFP expression continues to be highly expressed both in the lens fiber and epithelial cells of the developing E14.5 (D, I) and 
PND1 lens (E, J). Nuclear DAPI staining is blue, and the cytoskeletal phalloidin staining is red. Lens epithelial cells, e; lens fiber 
cells, f; lens pit, lp; lens vesicle, lv. Scale bar = 100 μm.
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lens pit, and subsequently expressed in both the lens epi-
thelium and fiber cells of the developing and newborn
lens. The only significant difference between EGFP and
αA-crystallin expression is much lower number of cells co-
expressing both proteins between E10.5 and E11.5 (Fig.
7A, B). The most likely reason for this difference is the
position-dependent distinct epigenetic regulatory mecha-
nisms [1,29] between the endogenous Cryaa locus and
randomly integrated 148 kb Cryaa BACs.
Previous studies conducted with traditional transgenics
suggested that DCR3 plays a specific role during "late" pri-
mary lens fiber cell differentiation [23]. Herein, the dele-
tion of DCR3 in both αA-BAC(ΔDCR3) and the 15 kb
Cryaa/EGFP trangenes did not have any prevailing effect
on the onset of EGFP expression in the lens, compared to
the expression of αA-BAC transgenes, as 5 out of 7 inde-
pendent lines (Table 1) showed EGFP expression in the
lens pit. The number of lines analyzed here is comparable
to similar transgenic studies [30-32]. Though DCR3 con-
Extralenticular expression of EGFP in 15 kb Cryaa/EGFP transgenics Figure 6
Extralenticular expression of EGFP in 15 kb Cryaa/EGFP transgenics. EGFP expression was observed at E9.5 (A), 
E10.5 (B), E11.5 (C) and (D) (higher magnification of (C)) (red arrows) in the hindbrain. The dashed white line illustrates the 
embryo and red arrowhead indicates EGFP expression in the lens. Scale bar = 1 mm.
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stituted a portion of the Cryaa 3'-UTR, its deletion seemed
not to affect the average expression of EGFP mRNA
obtained from both BAC transgenes (Table 2). Neverthe-
less, the possible function of DCR3 in αA-crystallin
mRNA processing and stability will require additional
experimentation.
A lens-specific chromatin domain between DCR1 and
DCR3 of the mouse Cryaa locus [23] may represent the
minimal size of the mouse Cryaa locus (Fig. 2A). Since
DCR3 appears to act as a "late" fiber-cell specific
enhancer, we examined a 15 kb Cryaa/EGFP  fragment
without DCR3. From our results, it was evident that the
genomic regions required for early temporal αA-crystallin
expression in the developing lens are present within this
15 kb modified genomic fragment, as EGFP expression
initiated in the lens pit at E10.5 in all four lines (Fig. 5).
In fact, it appears that more cells in the lens pit expressed
EGFP than endogenous αA-crystallin (Fig. 7K). This
observation requires additional comments, as the αA-
crystallin antibody is expected to recognize both αA-crys-
tallin and αA/EGFP fusion proteins. For example, it is pos-
sible that the epitopes recognized by the polyclonal
antiserum could be masked during the presumptive for-
mation of αA-crystallin/EGFP oligomers [33]. It is also
possible that the αA-crystallin/EGFP fusion proteins pre-
cipitate with other proteins to interfere with antibody rec-
ognition consistent with a range of lens opacities found in
all transgenic lenses studied (see Additional file 2). Even
if the protein remains unblocked, a constant, but
unknown, fraction of the protein is bound by antibody
under experimental conditions, whereas all of the trans-
gene-derived protein is EGFP-tagged. Moreover, the rela-
tive fluorescence produced by each tag is different, so,
although relative location can be estimated, relative
amounts of two proteins within any sample should never
be compared by this methodology. It is quite possible that
the fluorescence intensity elicited from EGFP at sufficient
concentration will always obscure the immunofluores-
cence signal from αA-crystallin under the experimental
conditions used.
In the past, αA-crystallin was referred to either as a lens-
specific, or as a lens-preferred protein with high expres-
sion in lens, and low expression in retina, spleen and thy-
mus [3-5,12,13]. More recent high-throughput data,
Transgene expression coincides with αA-crystallin protein Figure 7
Transgene expression coincides with αA-crystallin protein. Panels A-E are sections from αA-BAC mice; F-J are from 
αA-BAC(ΔDCR3) mice; and K-O are from the 15 kb Cryaa/EGFP mice. Red staining is αA-crystallin immunofluorescence, 
green is EGFP fluorescence and yellow represents co-localization of these two signals. Scale bar = 100 μm.
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available through the MGI and Unigene websites (see
Methods), expanded the previously established extralen-
ticular regions of αA-crystallin expression to the heart,
hindbrain, midbrain, cerebellum, pancreas, pituitary and
a few other tissues. Thus, expression of EGFP driven by the
15 kb Cryaa/EGFP in regions such as the hindbrain from
E10.5–14.5 (Fig. 6) may reflect its naturally low expres-
sion in this tissue. Analysis of guinea pig ζ-crystallin tran-
scriptional control indeed identified a brain-specific
regulatory region [34]. Interestingly, expression of EGFP,
supported by the 148 kb Cryaa BAC, was not detected by
qRT-PCR in spleen or thymus. One intriguing possibility
is that expression in these tissues originates via elements
shared with the adjacent U2af1 (expressed highly in thy-
mus relative to other tissues such as the eye) and Snf1lk
(expressed highly in spleen compared to other tissues)
genes, but not present in the 148 kb BAC. A U2 small
nuclear ribonucleoprotein auxiliary factor gene, U2af1, also
carried in this BAC, encodes a heterodimeric splicing fac-
tor [35]. The αA-BAC transgenic lines also exhibit elevated
U2af1 (data not shown), while expression of Snf1lk was
not tested due to its absence in the 148 kb BAC (see Fig.
2A).
Thus, the present data suggest that the genomic regions
required for αA-crystallin expression in the retina, spleen
and thymus are not present in the 148 kb Cryaa BAC and
may be located in genomic regions adjacent to this BAC
clone, or, as in the case of genes such as olfactory recep-
tors, these regulatory regions may be present on another
chromosome [36]. The interferon-γ locus on chromosome
10 is similarly regulated by elements within a locus
encoding the Th2 cytokine genes on chromosome 11 [30].
The complexity of the genome in relationship to the indi-
vidual genes and their regulation is far more complex than
previously thought [37,38].
Transgene positional/copy number effects and lens 
structural integrity
Although the general concept is that large transgenes, such
as BACs and YACs, are not susceptible to positional effects
[31], the lack of EGFP expression at E10.5 in 2 out of 3 αA-
BAC(ΔDCR3) transgenic lines suggests otherwise. Previ-
ous reports have indicated that generally one to five copes
of BACs are inserted into the genome [32], however recent
studies have suggested that this is not always the case. In
fact, analyses conducted by Chandler et al., 2007 reveal
that, while 50 % of transgenes are inserted as copies rang-
ing between 1–5, BACs can be inserted with much greater
copies, even up to almost 100 [32]. Additional BAC stud-
ies have reported copy numbers to be also in excess of 5
[39].
Analysis of the structural integrity of the adult lens reveals
that both BAC and 15 kb Cryaa/EGFP transgenics display
opacities (see Additional file 2). In fact, some of the αA-
BAC and 15 kb Cryaa/EGFP transgenic mice begin to show
signs of lens opacities upon eye opening (data not
shown). Morphologically these adult transgenic mouse
lenses appear to display nuclear cataracts, resembling
human and mouse models of Cryaa cataracts [40]. Given
the overpression of αA-crystallin/EGFP, one can speculate
plausible mechanisms contributing to lens opacities.
Firstly, it is possible that excess of αA-crystallin EGFP
fusion proteins interferes with the stoichiometric ratio of
αA and αB-crystallins in the α-crystallin heteroaggregate
complex, leading to the misfolding and precipitation of
proteins. Expression of the αA-crystallin/EGFP fusion pro-
tein may also play a role in disrupting other normal inter-
actions of lens proteins, resulting in protein aggregation
precipitation and cataract formation.
Conclusion
The present studies have shown that a modified genomic
fragment of 15 kb Cryaa/EGFP is sufficient to direct the
earliest onset of αA-crystallin/EGFP expression in the lens
pit (E10.5). The leading candidate regions to harbour this
early enhancer activity are four exons (1–3 and ins), and
evolutionarily conserved regions in introns 1 and 2 (see
Fig. 2A).
Methods
Insertion of EGFP into 148 kb Cryaa BAC
The mouse αA-crystallin  BAC clone RP-23-465G4 was
obtained from screening the mouse RPCI 23 library as we
described elsewhere [23]. αA-BAC was generated through
a homologous recombination, according to Lee et al.,
2001. Briefly, the BAC clone RP-23-465G4 was first trans-
formed by electroporation into SW105 E. coli cells har-
bouring a defective λ prophage (kindly provided by Dr.
Neil Copeland, NCI, Frederick, MD). A 2.4 kb linear tar-
geting cassette containing EGFP-pA, FRT-Kan-FRT
sequences was PCR amplified from pCS2+MTe-GFP-FRT-
kan-FRT plasmid (kindly provided by Dr. Jim Lauderdale,
University of Georgia, Athens, GA) with primers bearing
50 bp of homology to αA-crystallin and the plasmid. This
targeting vector was PCR amplified with primers: 5'-
CTCTCCTGCTCCCTGTCTGCGGATGGCATGCTGACCTT
CTCTGGCCCCAAGGTCATGGTGAGCAAGGGCGAG-3'
and 5'-CTCCCGTGACACAGGAATGGCCCTCTCGCTGTG
GCCAGCATCCAAACCGGACTGTATTCCAGAAGTAGTG
AG-3' using the following conditions: 95°C, 2 min for 1
cycle; 95°C, 30 sec; 60°C, 30 sec; 72°C, 2 min 30 sec for
30 cycles; 72°C, 7 min for 1 cycle. The PCR product was
separated by gel electrophoresis followed by purification
with the Qiaquick gel extraction kit (Qiagen) and the plas-
mid template removed by digestion with DpnI. Homolo-
gous recombination was conducted by electroporating
300 ng of the targeting vector into SW105 competent cells
containing BAC clone RP-23-465G4, with a Bio-Rad geneBMC Developmental Biology 2008, 8:88 http://www.biomedcentral.com/1471-213X/8/88
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pulser (1.75 kV, 25 μF, 200 Ω). Recombinants were veri-
fied by PCR using primers (5'-TTTGGCGCGCCAAGCCAG
TTCCATACCCTGA-3' and 5'-CGGCGAGCTGCACGCT-
GCCGTCC-3'), and a single colony was used for FLP
induction with 10% L (+) arabinose. Colonies were plated
on chloramphenicol LB plates, and modified BAC's were
verified by sequencing and restriction analysis.
The BAC clone RP-23-465G4 was modified, using the
shuttle vector pLD53.SCAEB to insert EGFP into the third
exon of αA-crystallin, to generate αA-BAC(ΔDCR3) trans-
genics [26]. Briefly, two regions homologous to αA-crystal-
lin  were PCR amplified using the following primers:
Homologous region 1, 5'-TTTGGCGCGCCAAGCCAGT-
TCCATACCCTGA-3' and 5'-GTTTCTCCTCCCGTGACAC
A-3'; homologous region 2, 5'-TTAATTAAACACCACG-
GAACATACCACA-3' and 5'-CCGGCCGGGCTTGGACAT
CCAGGAACAG-3'. The homologous regions were cloned
into the AscI/SmaI and PacI/FseI sites of the pLD53.SCAEB
shuttle vector, respectively. 1 μg of the shuttle vector was
electroporated into αA-crystallin  BAC competent cells,
using a Bio-rad gene pulser (1.8 kV, 25 μF, 200 Ω), and
cointegrates were selected on LB plates containing chlo-
ramphenicol (20 μg/ml) and ampicillin (50 μg/ml).
Cointegrates were analyzed by PCR with the following
primers: 5'-GATGAGGAAGCTGGGTGGTA-3' and 5'-
CGGCGAGCTGCACGCTGCCGTCC-3', and a correct
integrate was subsequently resolved by growing in LB con-
taining chloramphenicol and ampicillin and plated on LB
+ chloramphenicol + sucrose plates. Resolved colonies
were analyzed by PCR with the following primers: 5'-
CCTACGGCGTGCAGTGCTTCAGC-3' and 5'-CAAA-
GACAGCTCCATGCTGA-3', and modified clones were
verified by sequencing.
Isolation of a 15 kb αA-crystallin/EGFP fragment
The 15 kb αA-crystallin/EGFP construct was generated by
digesting  αA-BAC(ΔDCR3) with XmaI  and  SpeI. The
digests were run on a 0.8% agarose gel (Seaplaque GTG)
overnight, and stained with SYBR®  Gold (Molecular
Probes). A 15 kb band was excised from the gel and elec-
troeluted in TAE buffer. The DNA was precipitated with
100% ethanol and sodium acetate (pH 5.2; 300 mM),
then washed with 70% ethanol. The 15 kb fragment con-
taining 14 kb genomic DNA and 1.0 kb of EGFP/poly A
was cloned into pBluescript SK II vector sites, XmaI and
SpeI.
Generation of transgenic mice
αA-BAC and αA-BAC(ΔDCR3) DNAs for pronuclear injec-
tion were isolated using the Qiagen endonuclease-free
mega purification kit (Qiagen) according to the manufac-
turer's instructions, with the exception that the volume of
P1, P2 and P3 was increased three times. Circular BACs
and the the 15 kb genomic fragment DNA were injected
into FVB/N fertilized oocytes (AECOM Transgenic and
Gene Targeting Facility and NEI Genetic Engineering
Facility). αA-BAC transgenic mice were identified by PCR
of genomic mouse tail DNA with the following primers:
5'-CCTACGGCGTGCAGTGCTTCAGC-3' and 5'-GTTCTC-
CTCCCGTGACACA-3'. The primers used for αA-
BAC(ΔDCR3) and the 15 kb locus transgenic lines were:
5'-TTTGGCGCGCCAAGCCAGTTCCATACCCTGA-3' and
5'-CGGCGAGCTGCACGCTGCCGTCC-3'.
Immunofluorescence
Embryos were fixed in 4% paraformaldehyde, cryopro-
tected with 30 % sucrose in PBS, and embedded in tissue
freezing medium™ (Triangle Biomedical Sciences) for cry-
osectioning. Transverse cryostat sections (6 μm) were col-
lected, washed with PBS, and incubated for 30 minutes
with Image iT™ FX signal enhancer (Molecular Probes).
Slides were then washed in PBS and incubated overnight
at 4°C with the primary antibody, αA-crystallin (1:1000)
(sc-22743, Santa Cruz Biotechnology) diluted in PBS con-
taining 1% BSA and 0.05% Triton-X100. Sections were
washed twice for 10 minutes in PBS and incubated for 45
minutes with the secondary antibody, goat anti-rabbit
Alexa Fluor® 568 (1:500) (Molecular Probes) and with
DAPI (1:50,000) (Molecular Probes). Sections stained
with rhodamine-phalloidin (1:300) (Molecular Probes)
and DAPI (1:50,000) were incubated for 30 minutes at
room temperature. Slides were washed with PBS and
mounted with Vectashield (Vector). Images were taken
with a Leica AOBS laser scanning confocal microscope.
Quantitative RT-PCR (qRT-PCR)
RNA was isolated from dissected tissues with Trizol® Rea-
gent (Invitrogen) and digested with DNase I (Promega)
according to manufacturer's instructions. cDNA was gen-
erated with Superscript™ III Reverse Transcriptase (Invitro-
gen), and the template was diluted 1:10. Primers used for
qT-PCR were: αA-crystallin (5'-GAGATTCACG-
GCAAACACAA-3' and 5'-ACATTGGAAGGCAGACGGTA-
3'), and EGFP (5'-ACGACGGCAACTACAAGACC-3' and
5'-GTCCTCCTTGAAGTCGATGC-3'; 5'-CACATGAAGCAG
CACGACTT-3' and 5'-GGTCTTGTAGTTGCCGTCGT-3').
Primers for αA-crystallin recognize both endogenous and
the fusion αA-crystallin-EGFP cDNA. The relative expres-
sion level of αA-crystallin was normalized by the EGFP
fusion protein average versus endogenous αA-crystallin.
Transgenic copy number analysis
Genomic DNA was isolated by digesting tissue with lysis
buffer (100 mM Tris HCL, pH 8.0, 5 mM EDTA, 0.2 %
SDS, 200 mM NaCl) containing Proteinase K (100 μg/ml)
at 55°C. Phenol/chloroform/isoamyl alcohol (Invitro-
gen) extractions were performed, and DNA was precipi-
tated with isopropanol. Quantitative PCR was conducted
to determine the number of copies of the BAC transgene,BMC Developmental Biology 2008, 8:88 http://www.biomedcentral.com/1471-213X/8/88
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using the following primers: αA-crystallin (5'-GAGAG-
GGCCATTCCTGTGT-3' and 5'-AGGGGACAACCAAGGT-
GAG-3'), (5'-GGGTGCTGGTCTACTTCCAG-3' and 5'-
AACCACGACATCCGAAAAAG-3') and CCNI (5'-TCT-
TCTCCCTCCTCAGACG-3' and 5'-CCGTTACCACCTCAT-
GATCC-3'); B2M (5'-CCCTGGCTGGCTCTCATT-3' and
5'-ACTGAAGCGACCGCGACT-3') for normalization.
Bioinformatic searches
Mouse Genome Informatics (MGI) server http://
www.informatics.jax.org and Unigene EST Profile Viewer
http://www.ncbi.nlm.nih.gov/UniGene were used to
examine expression data of Cryaa, Snf1lk and U2af1 (see
Fig. 2A) mouse genes. The MGI server also provides infor-
mation regarding Cryaa  phenotypic alleles http://
www.informatics.jax.org/phenotypes.shtml.
Supplementary methods
Mice lenses were dissected from animals ranging in age
from 3–6 months. Opacities were demonstrated micro-
scopically with an Olympus IX70 (Zeiss 1.25× NA 0.035)
and pictures were taken with Cooke Sensicam Cooled
CCD.
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